caremark tirzepatide CVS is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE CVS brings back coverage for

There was a case reported of a 46-year-old man with increasing visual deterioration and difficulty with night driving over three months, during which he had been drinking a gallon of tonic water a day

Interested healthcare providers will need to submit a completed questionnaire to Empower for approval to order controlled substances for office-use.

Amble Health Review About Amble Health Amble Health is a telehealth clinic founded in 2023 that offers affordable access to compounded GLP1 medications for weight loss

However, the risk of kidney disease should not be overlooked ( 2 Methods This systematic review of case reports was conducted and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement ( 2.1 Search strategies A comprehensive literature search was conducted using the PubMed/MEDLINE, Web of Science, Embase, the Cochrane Library, and CNKI databases to identify relevant case reports and case series published in English or Chinese from database inception to October 31, 2025

If you had insulin resistance before starting semaglutide, the condition likely returns when you stop

When choosing between these options, clinicians consider efficacy, tolerability, patient preference, and comorbidities